Dr. Brumme leads the BC-CfE Laboratory’s precision medicine program, which provides HIV and HCV clinical diagnostic services for clients in British Columbia and across Canada. These services include genotypic drug resistance testing, pharmacogenomic screening and antiretroviral drug level monitoring. The BC-CfE Laboratory is accredited by the Diagnostic Accreditation Program of the College of Physicians and Surgeons of British Columbia (DAP), the College of American Pathologists (CAP) and is a WHO-designated Specialized HIV Drug Resistance Testing Laboratory. Dr. Brumme is also a member of the BC-CfE’s Committee for Drug Evaluation.